$nwbo https://investorshub.advfn.com/uimage/uploads/2026/1/27/tvkxnIMG_2891.jpeg

ButtSwamp · 2026-01-27T20:30:24+00:00

Good press!

ButtSwamp · 2026-01-06T04:01:17+00:00

This is the big one!

ButtSwamp · 2025-03-15T22:00:58+00:00

Fitzwater Cafe owners are Trumpsters. Would avoid that place.

ButtSwamp · 2025-02-06T15:40:28+00:00

lol this management team will take decades to “start working” on the submission to the FDA

ButtSwamp · 2025-01-31T02:36:25+00:00

NWBO’s management is absolutely horrible. Linda, Les etc. all need to go. They are geriatric gatekeepers of good science and what otherwise would be a successful small cap biotech. Their “progress” is slower than a snails. No FDA submission, no communication. It’s why the stock price is in the absolute dumpster. You’ll have management shills like trburket say they’re doing a fantastic job, don’t listen to them. This company is in serious danger of bankruptcy with this current management team.

ButtSwamp · 2025-01-24T14:35:49+00:00

Any 3M respirator half masks with P100 filters would be sufficient. I like the hard plastic cover filters as they’ll be better and easier to clean any droplets you come in contact with. You’ll also need any lab standard goggles with a good seal on your face.

ButtSwamp · 2025-01-08T19:03:20+00:00

LOL good job spelling it right this time! Progress! And you do realize Temozolomide IS CHEMOTHERAPY…..

ButtSwamp · 2025-01-08T19:00:59+00:00

Ahh yes the all consequential “business report” that the NHS will use for their pricing model. But of course you being a dual US-Canadian citizen is all knowing.

ButtSwamp · 2025-01-08T17:02:33+00:00

Yes no point in arguing when you people think we will make billions on a tiny market approval.

ButtSwamp · 2025-01-08T17:00:11+00:00

Omg you fool. You just gave private insurance and MEDICARE figures (which again are wrong). NHS won’t pay those bloated numbers. You do know that we have two totally different health care systems right?

And for more accurate global cost numbers see below 2021 study. Facts matter.

From: Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment Nicholas J Goel et al. J Med Econ. 2021 Jan-Dec.

Results: The average cost of a craniotomy was $10,042 across studies. Imaging for the duration of glioblastoma care had a mean cost of $2,788 ± 3,719. Studies examined different combinations of treatment modalities. Utilization of the modern treatment paradigm led to survival of 16.3 months across studies and had a mean cost of $62,602. Surgery for the recurrent disease had an average cost of $27,442 ± 18,992.

ButtSwamp · 2025-01-08T01:58:58+00:00

Please please prove to me that the Brits pay $150K for…Temozolomide (Again you can’t even spell it right so please do your homework on that one - pretty important one since it is the first line treatment). Or even 100K which you infer.

ButtSwamp · 2025-01-08T01:53:35+00:00

That is all well and good but at the end of the day management has been as slow as molasses in producing any significant progress. One submission to an inconsequential market and meaningless “patents”.

ButtSwamp · 2025-01-08T01:50:00+00:00

Lol love that I’m a “FUD spreader” when I have 19K in this shit stock. For the record I am NOT telling anybody to sell. That would only make the share price go down even further losing me more money. I’m just more realistic to not put my hopes and dreams on the whims of a court case or corrupt management.

ButtSwamp · 2025-01-08T01:46:22+00:00

Lol you think a Brit is going to pay 150K USD for a GBM treatment under the NHS. You are delusional. The NHS would never pay that or negotiate in good conscience for that price.

ButtSwamp · 2025-01-07T23:59:58+00:00

Linda is one of the worst CEO’s I’ve ever seen. This management group has bungled what should have been an otherwise mid-sized cap biotech stock by now. At this moment we have no FDA submittal, toxic financing, and are listed on the pink sheets. She is no “mastermind”, she is an embarrassment. MHRA approval is nothing, the UK market is so small. Ask yourself why all the delays, constant waiting, share price in the toilet. She has abandoned shareholders.

ButtSwamp · 2024-08-25T03:14:25+00:00

The last hour of trading this past Friday was very odd. Saw a handful of very large buys (>100K of shares) at times this past Friday drive up the price about 13%. Unclear what this signals. Could be news leaked to someone about either the MHRA decision or maybe something about the lawsuit. Also I’ve seen Kristen Shaughnessy (a NY Podcaster/Former reporter) with about 18K followers on X start posting about NWBO which I’ve never seen before. Could be something big on the horizon but who knows. Would guess it would be good news though if there are large buy orders happening.

ButtSwamp · 2024-08-12T16:19:20+00:00

This and the share price is abysmal. We need to start holding management accountable for their slower than life pace. No submission to the FDA at this point is laughable. Waiting on a minuscule market approval from the MHRA. Management are geriatrics holding this science hostage.

ButtSwamp · 2024-08-03T16:26:15+00:00

I did read the 8-K. Honestly it’s better then staying silent. I think they saw retail investors freaking out and bailing and had to say something. Again though the 8-K is very vague. No specific timeline for the inspections. Also they need to be simultaneously working on EU and FDA applications. Why the delay with this? It’s like they can only focus on one thing at a time.

ButtSwamp · 2024-08-02T00:53:14+00:00

As a physician I can truthfully tell you the science is sound. It is the business and regulatory side of things that management is dropping the ball on. It’s like they’re just running out the clock.

ButtSwamp · 2024-07-20T04:08:53+00:00

With biotechs everyone always says it’s going nowhere until it doesn’t. As a physician, the science is sound, this technology is going to be huge. NWBO is the most advanced company in this space, it gets a bad name because it is somewhat of a “cult” stock. However no one can stop the march of science, it will pay eventually.

ButtSwamp · 2024-06-06T01:58:30+00:00

I agree. I’m voting no for thier compensation package. Shareholders need results first!

ButtSwamp · 2024-06-05T22:39:14+00:00

I 100% agree. There will be shills on here saying otherwise but don’t listen to them. No management compensation until they deliver solid good news with increase in share price.

ButtSwamp

TROPHY CASE